Literature DB >> 1554355

Structural and functional comparison of two human liver dihydrodiol dehydrogenases associated with 3 alpha-hydroxysteroid dehydrogenase activity.

Y Deyashiki1, H Taniguchi, T Amano, T Nakayama, A Hara, H Sawada.   

Abstract

Two monomeric dihydrodiol dehydrogenases with pI values of 5.4 and 7.6 were co-purified with androsterone dehydrogenase activity to homogeneity from human liver. The two enzymes differed from each other on peptide mapping and in their heat-stabilities; with respect to the latter the dihydrodiol dehydrogenase and 3 alpha-hydroxysteroid dehydrogenase activities of the respective enzymes were similarly inactivated. The pI 5.4 enzyme was equally active towards trans- and cis-benzene dihydrodiols, and towards (S)- and (R)-forms of indan-1-ol and 1,2,3,4-tetrahydronaphth-1-ol and oxidized the 3 alpha-hydroxy group of C19-, C21- and C24-steroids, whereas the pI 7.6 enzyme showed high specificity for trans-benzene dihydrodiol, (S)-forms of the alicyclic alcohols and C19- and C21-steroids. Although the two enzymes reduced various xenobiotic carbonyl compounds and the 3-oxo group of C19- and C21-steroids, and were A-specific in the hydrogen transfer from NADPH, only the pI 5.4 enzyme showed reductase activity towards 7 alpha-hydroxy-5 beta-cholestan-3-one and dehydrolithocholic acid. The affinity of the two enzymes for the steroidal substrates was higher than that for the xenobiotic substrates. The two enzymes also showed different susceptibilities to the inhibition by anti-inflammatory drugs and bile acids. Whereas the pI-5.4 enzyme was highly sensitive to anti-inflammatory steroids, showing mixed-type inhibitions with respect to indan-1-ol and androsterone, the pI 7.6 enzyme was inhibited more potently by non-steroidal anti-inflammatory drugs and bile acids than by the steroidal drugs, and the inhibitions were all competitive. These structural and functional differences suggest that the two enzymes are 3 alpha-hydroxysteroid dehydrogenase isoenzymes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1554355      PMCID: PMC1130850          DOI: 10.1042/bj2820741

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  25 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  Purification and properties of 3 alpha-hydroxysteroid dehydrogenase as a 3-keto bile acid reductase from human liver cytosol.

Authors:  K Kudo; Y Amuro; T Hada; K Higashino
Journal:  Biochim Biophys Acta       Date:  1990-08-28

3.  Identity of dihydrodiol dehydrogenase and 3 alpha-hydroxysteroid dehydrogenase in rat but not in rabbit liver cytosol.

Authors:  W Wörner; F Oesch
Journal:  FEBS Lett       Date:  1984-05-21       Impact factor: 4.124

4.  Purification and properties of a 3 alpha-hydroxysteroid dehydrogenase of rat liver cytosol and its inhibition by anti-inflammatory drugs.

Authors:  T M Penning; I Mukharji; S Barrows; P Talalay
Journal:  Biochem J       Date:  1984-09-15       Impact factor: 3.857

5.  Separation and properties of multiple forms of dihydrodiol dehydrogenase from hamster liver.

Authors:  H Sawada; A Hara; M Nakagawa; F Tsukada; M Ohmura; K Matsuura
Journal:  Int J Biochem       Date:  1989

6.  Isolation of multiple forms of indanol dehydrogenase associated with 17 beta-hydroxysteroid dehydrogenase activity from male rabbit liver.

Authors:  A Hara; K Kariya; M Nakamura; T Nakayama; H Sawada
Journal:  Arch Biochem Biophys       Date:  1986-08-15       Impact factor: 4.013

7.  Purification and characterization of NADP+-dependent 3 alpha-hydroxysteroid dehydrogenase from mouse liver cytosol.

Authors:  A Hara; Y Inoue; M Nakagawa; F Naganeo; H Sawada
Journal:  J Biochem       Date:  1988-06       Impact factor: 3.387

8.  Isolation of proteins with carbonyl reductase activity and prostaglandin-9-ketoreductase activity from chicken kidney.

Authors:  A Hara; Y Deyashiki; M Nakagawa; T Nakayama; H Sawada
Journal:  J Biochem       Date:  1982-12       Impact factor: 3.387

9.  Rat liver cytoplasmic dihydrodiol dehydrogenase. Purification to apparent homogeneity and properties.

Authors:  K Vogel; P Bentley; K L Platt; F Oesch
Journal:  J Biol Chem       Date:  1980-10-25       Impact factor: 5.157

10.  3 alpha-hydroxysteroid dehydrogenase activity of the Y' bile acid binders in rat liver cytosol. Identification, kinetics, and physiologic significance.

Authors:  A Stolz; H Takikawa; Y Sugiyama; J Kuhlenkamp; N Kaplowitz
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

View more
  15 in total

Review 1.  Aldo-keto reductases and formation of polycyclic aromatic hydrocarbon o-quinones.

Authors:  Trevor M Penning
Journal:  Methods Enzymol       Date:  2004       Impact factor: 1.600

2.  Reductive metabolism of nabumetone by human liver microsomal and cytosolic fractions: exploratory prediction using inhibitors and substrates as marker probes.

Authors:  Kaori Matsumoto; Tetsuya Hasegawa; Junichi Koyanagi; Tamiko Takahashi; Masayuki Akimoto; Kenji Sugibayashi
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2015-06       Impact factor: 2.441

3.  Kinetic alteration of a human dihydrodiol/3alpha-hydroxysteroid dehydrogenase isoenzyme, AKR1C4, by replacement of histidine-216 with tyrosine or phenylalanine.

Authors:  T Ohta; S Ishikura; S Shintani; N Usami; A Hara
Journal:  Biochem J       Date:  2000-12-15       Impact factor: 3.857

4.  Identification of amino acid residues responsible for differences in substrate specificity and inhibitor sensitivity between two human liver dihydrodiol dehydrogenase isoenzymes by site-directed mutagenesis.

Authors:  K Matsuura; Y Deyashiki; K Sato; N Ishida; G Miwa; A Hara
Journal:  Biochem J       Date:  1997-04-01       Impact factor: 3.857

5.  Sequence of the cDNA of a human dihydrodiol dehydrogenase isoform (AKR1C2) and tissue distribution of its mRNA.

Authors:  H Shiraishi; S Ishikura; K Matsuura; Y Deyashiki; M Ninomiya; S Sakai; A Hara
Journal:  Biochem J       Date:  1998-09-01       Impact factor: 3.857

6.  Roles of the C-terminal domains of human dihydrodiol dehydrogenase isoforms in the binding of substrates and modulators: probing with chimaeric enzymes.

Authors:  K Matsuura; A Hara; Y Deyashiki; H Iwasa; T Kume; S Ishikura; H Shiraishi; Y Katagiri
Journal:  Biochem J       Date:  1998-12-01       Impact factor: 3.857

7.  Molecular cloning of two human liver 3 alpha-hydroxysteroid/dihydrodiol dehydrogenase isoenzymes that are identical with chlordecone reductase and bile-acid binder.

Authors:  Y Deyashiki; A Ogasawara; T Nakayama; M Nakanishi; Y Miyabe; K Sato; A Hara
Journal:  Biochem J       Date:  1994-04-15       Impact factor: 3.857

8.  Crystal structure of human liver Delta4-3-ketosteroid 5beta-reductase (AKR1D1) and implications for substrate binding and catalysis.

Authors:  Luigi Di Costanzo; Jason E Drury; Trevor M Penning; David W Christianson
Journal:  J Biol Chem       Date:  2008-04-11       Impact factor: 5.157

9.  Activation of human liver 3 alpha-hydroxysteroid dehydrogenase by sulphobromophthalein.

Authors:  K Matsuura; Y Tamada; Y Deyashiki; Y Miyabe; M Nakanishi; I Ohya; A Hara
Journal:  Biochem J       Date:  1996-01-01       Impact factor: 3.857

10.  Relationship of human liver dihydrodiol dehydrogenases to hepatic bile-acid-binding protein and an oxidoreductase of human colon cells.

Authors:  A Hara; K Matsuura; Y Tamada; K Sato; Y Miyabe; Y Deyashiki; N Ishida
Journal:  Biochem J       Date:  1996-01-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.